Cargando…

Barriers and Facilitators to the Elimination of Asbestos Related Diseases—Stakeholders’ Perspectives

Despite sound scientific knowledge and evidence that any exposure to asbestos fibers in all of its forms, are carcinogenic to humans, its presence, use and trade is still substantial, including in the World Health Organization (WHO) European Region. Banning the production and use of all forms of asb...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincenten, Joanne, George, Frank, Martuzzi, Marco, Schröder-Bäck, Peter, Paunovic, Elizabet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664770/
https://www.ncbi.nlm.nih.gov/pubmed/29065497
http://dx.doi.org/10.3390/ijerph14101269
_version_ 1783275053846102016
author Vincenten, Joanne
George, Frank
Martuzzi, Marco
Schröder-Bäck, Peter
Paunovic, Elizabet
author_facet Vincenten, Joanne
George, Frank
Martuzzi, Marco
Schröder-Bäck, Peter
Paunovic, Elizabet
author_sort Vincenten, Joanne
collection PubMed
description Despite sound scientific knowledge and evidence that any exposure to asbestos fibers in all of its forms, are carcinogenic to humans, its presence, use and trade is still substantial, including in the World Health Organization (WHO) European Region. Banning the production and use of all forms of asbestos, as recommended by the International Labour Organization (ILO) and WHO, has been proven as the most efficient evidence-based strategy to eliminate Asbestos Related Diseases (ARDs). To effectively move elimination of ARDs forward, attaining a greater understanding of key stakeholders perspectives was identified as an important action. The WHO Regional Office for Europe, the European Centre for Environment and Health, undertook semi-structured interviews, and follow-up discussions with diverse representatives dealing professionally with asbestos. The interview questionnaire was developed based on the current ARDs WHO Report, the Evidence Implementation Model for Public Health and categories of the theory of diffusion. Data were attained on three main questions within the interview questionnaire: (1) Identifying barriers to implementation of WHO evidence-based asbestos recommendations; (2) Describing roles of key stakeholders; and, (3) Proposing possible solutions. The results demonstrated use of sound and convincing scientific evidence along with economic evidence and facilitators can be used to achieve evidence-based policy development, and comprehensive diverse actions.
format Online
Article
Text
id pubmed-5664770
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-56647702017-11-06 Barriers and Facilitators to the Elimination of Asbestos Related Diseases—Stakeholders’ Perspectives Vincenten, Joanne George, Frank Martuzzi, Marco Schröder-Bäck, Peter Paunovic, Elizabet Int J Environ Res Public Health Article Despite sound scientific knowledge and evidence that any exposure to asbestos fibers in all of its forms, are carcinogenic to humans, its presence, use and trade is still substantial, including in the World Health Organization (WHO) European Region. Banning the production and use of all forms of asbestos, as recommended by the International Labour Organization (ILO) and WHO, has been proven as the most efficient evidence-based strategy to eliminate Asbestos Related Diseases (ARDs). To effectively move elimination of ARDs forward, attaining a greater understanding of key stakeholders perspectives was identified as an important action. The WHO Regional Office for Europe, the European Centre for Environment and Health, undertook semi-structured interviews, and follow-up discussions with diverse representatives dealing professionally with asbestos. The interview questionnaire was developed based on the current ARDs WHO Report, the Evidence Implementation Model for Public Health and categories of the theory of diffusion. Data were attained on three main questions within the interview questionnaire: (1) Identifying barriers to implementation of WHO evidence-based asbestos recommendations; (2) Describing roles of key stakeholders; and, (3) Proposing possible solutions. The results demonstrated use of sound and convincing scientific evidence along with economic evidence and facilitators can be used to achieve evidence-based policy development, and comprehensive diverse actions. MDPI 2017-10-22 2017-10 /pmc/articles/PMC5664770/ /pubmed/29065497 http://dx.doi.org/10.3390/ijerph14101269 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vincenten, Joanne
George, Frank
Martuzzi, Marco
Schröder-Bäck, Peter
Paunovic, Elizabet
Barriers and Facilitators to the Elimination of Asbestos Related Diseases—Stakeholders’ Perspectives
title Barriers and Facilitators to the Elimination of Asbestos Related Diseases—Stakeholders’ Perspectives
title_full Barriers and Facilitators to the Elimination of Asbestos Related Diseases—Stakeholders’ Perspectives
title_fullStr Barriers and Facilitators to the Elimination of Asbestos Related Diseases—Stakeholders’ Perspectives
title_full_unstemmed Barriers and Facilitators to the Elimination of Asbestos Related Diseases—Stakeholders’ Perspectives
title_short Barriers and Facilitators to the Elimination of Asbestos Related Diseases—Stakeholders’ Perspectives
title_sort barriers and facilitators to the elimination of asbestos related diseases—stakeholders’ perspectives
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664770/
https://www.ncbi.nlm.nih.gov/pubmed/29065497
http://dx.doi.org/10.3390/ijerph14101269
work_keys_str_mv AT vincentenjoanne barriersandfacilitatorstotheeliminationofasbestosrelateddiseasesstakeholdersperspectives
AT georgefrank barriersandfacilitatorstotheeliminationofasbestosrelateddiseasesstakeholdersperspectives
AT martuzzimarco barriersandfacilitatorstotheeliminationofasbestosrelateddiseasesstakeholdersperspectives
AT schroderbackpeter barriersandfacilitatorstotheeliminationofasbestosrelateddiseasesstakeholdersperspectives
AT paunovicelizabet barriersandfacilitatorstotheeliminationofasbestosrelateddiseasesstakeholdersperspectives